Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rymanyl
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral, Topical
01
Overview
Rymanyl is a proprietary Ayurvedic herbomineral formulation developed by Charak Pharma. It is primarily indicated for the management of musculoskeletal disorders, joint pain, and inflammatory joint conditions such as osteoarthritis, rheumatoid arthritis, spondylitis, sciatica, and lumbago. Formulated with key natural ingredients including Guggul (*Balsamodendron mukul*), Nirgundi (*Vitex negundo*), Eranda (*Ricinus communis*), and Shyonaka (*Oroxylum indicum*), Rymanyl exhibits anti-inflammatory, analgesic, and immunomodulatory properties. It is available in oral capsule and topical liniment forms to help reduce joint stiffness, alleviate pain, and improve overall joint mobility and flexibility.
- Brand names
- RymanylRymanyl CapsuleRymanyl Liniment
Beyond the preview
Go deeper on Rymanyl.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rymanyl.